Company
Wuhan BBT Mini-invasive Medical Tech. Co., Ltd.
25Years of experience
in one-stop service

Wuhan BBT Mini-invasive Tech Co., Ltd., founded in 1999, is the inventor of the world's first "RFC-Self-coagulation Knife Treatment System". Now, the Company is located in the China Optics Valley High-tech Park on the shore of the beautiful East Lake in Wuhan. The mission of the company is to "healthy our female, benefiting all mankind" To date, our ultrasonic surgical systems have entered more than 20 countries, including South Korea, Vietnam, Italy, Poland, Brazil, and Turkey.

 

Our company comprises the R&D, production, and sales departments. The R&D department boasts over 150 employees with extensive experience in electronic R&D and mechanical design, responsible for product design and development. Our production department is equipped with more than 20 CNC lathes, including imported processing centers and ultrasonic welding machines for production. The production building covers an area of over 1,000 square meters with a daily capacity of over 1,000 units. Meanwhile, our sales team operates nationwide and globally.

 
1,000㎡
covers an area
150+
R&d personnel
25+
Years of experience
20+
Exporting country
01

Production Equipment

Our company comprises the R&D, production, and sales departments. The R&D department boasts over 150 employees with extensive experience in electronic R&D and mechanical design, responsible for product design and development. Our production department is equipped with more than 20 CNC lathes, including imported processing centers and ultrasonic welding machines for production. The production building covers an area of over 1,000 square meters with a daily capacity of over 1,000 units. Meanwhile, our sales team operates nationwide and globally.

02

Our Service

At Wuhan BBT Medical, we are dedicated to exceeding your expectations with exceptional service. Our team works tirelessly to ensure seamless, efficient, and highly satisfactory interactions with us.

We understand your unique needs and offer personalized solutions tailored to your specific requirements. Whether you need assistance, information, or comprehensive support, we are here for you every step of the way.

Our service aims to meet and exceed your expectations.

Experience the difference of our service and let us be your trusted partner in your journey to success

 

 

Products Description

 

Department

Specific indications

General Surgery

Open surgery

Stomach surgery, LAR, liver resection, thyroid surgery, cholecystectomy, hemorrhoidectomy

Laparoscopic surgery

Colorectal Surgery, Stomach Surgery, Cholecystectomy, Spleen Surgery, Thyroid Surgery

Urology

Open surgery

Kidney, adrenalectomy, prostatectomy, cystectomy

Laparoscopic surgery

Kidney, adrenalectomy, prostatectomy, cystectomy

Obstetrics and Gynecology

Open surgery

Myomectomy, adnexectomy, total hysterectomy, pelvic lymph node dissection

Laparoscopic surgery

Myomectomy, adnexectomy, total hysterectomy, pelvic lymph node dissection

ENT Department

Thyroid, parotid gland

 

 

Production Market

The company's products have achieved tremendous success in the domestic market, not only covering the top three hospitals nationwide but also penetrating into grassroots medical institutions at the county and township levels. This is thanks to our outstanding product quality and excellent standards, which have gained high recognition and trust among gynecological hospitals and patients. Meanwhile, in the international market, our products are exported to more than 30 countries in Southeast Asia, South America, and Europe, holding a place in fiercely competitive markets. Last year, our foreign sales reached 150 million RMB and continue to maintain stable growth momentum. In addition, the company actively participates in various industry exhibitions and academic exchange activities to expand brand awareness globally and strengthen partnerships. Through continuous innovation and technological advancement, the company is committed to providing better medical solutions for more patients in need while continuing to explore emerging markets to achieve broader international development goals.